Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02411786
What this trial is testing

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 40
Testing effectiveness (Phase 2)Looking for participantsNCT05011383
What this trial is testing

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

Who this might be right for
Metastatic Prostate Cancer
VA Office of Research and Development 51
Early research (Phase 1)Ended earlyNCT01741753
What this trial is testing

BKM120+Abiraterone Acetate for Metastatic CRPC

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00964002
What this trial is testing

Efavirenz in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Bergonié 61
Large-scale testing (Phase 3)Study completedNCT04887506
What this trial is testing

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Castration-sensitive Prostate CancerMetastatic Prostate Cancer
Tavanta Therapeutics 107
Early research (Phase 1)Ended earlyNCT02744287
What this trial is testing

Safety and Activity Study of PSCA-Targeted CAR-T Cells (BPX-601) in Subjects With Selected Advanced Solid Tumors

Who this might be right for
Metastatic Castration-resistant Prostate CancerMetastatic Prostate Cancer
Regeneron Pharmaceuticals 52
Large-scale testing (Phase 3)Looking for participantsNCT05983783
What this trial is testing

Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC

Who this might be right for
Metastatic Prostate CancerHormone Sensitive Prostate CancerChemotherapy Effect
The First Affiliated Hospital with Nanjing Medical University 200
Testing effectiveness (Phase 2)UnknownNCT00003183
What this trial is testing

Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Hope Cancer Institute, Inc. 64
Testing effectiveness (Phase 2)Ended earlyNCT00945477
What this trial is testing

Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade

Who this might be right for
Prostate Cancer
Illinois CancerCare, P.C. 11
Not applicableActive Not RecruitingNCT07597369
What this trial is testing

Clinically Actionable Tumor-Associated Antigens in Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate CancerMetastatic Prostate Cancer (mCRPC)
Peking University First Hospital 1,600
Not applicableLooking for participantsNCT06850545
What this trial is testing

Kuopio Lutetium-177 Study in Patients with PSMA-Positive Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate AdenocarcinomaPSMA PET-Positive Castration-Resistant Prostate Cancer
Kuopio University Hospital 150
Testing effectiveness (Phase 2)UnknownNCT00684970
What this trial is testing

Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (CRPC)
Tiltan Pharma Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06632977
What this trial is testing

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

Who this might be right for
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 474
Testing effectiveness (Phase 2)Active Not RecruitingNCT04009967
What this trial is testing

Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03181867
What this trial is testing

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Who this might be right for
Prostate NeoplasmsProstatic CancerProstate Cancer+2 more
National Cancer Institute (NCI) 360
Early research (Phase 1)Study completedNCT01296139
What this trial is testing

Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)UnknownNCT05167175
What this trial is testing

The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation

Who this might be right for
Prostate CancerProstate CarcinomaMetastatic Prostate Cancer
Hongqian Guo 30
Large-scale testing (Phase 3)Study completedNCT00002881
What this trial is testing

Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Testing effectiveness (Phase 2)Looking for participantsNCT07111507
What this trial is testing

Tarlatamab for People With Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Memorial Sloan Kettering Cancer Center 32
Next Page